Aspiriant LLC’s HF Sinclair DINO Stock Holding History

Aspiriant LLC’s Portfolio DINO Stock Details DINO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18,605	Closed	-$610K	–	218
2016 Q4	$610K	Buy	+18,605	New	+$516K	0.06%	128

Other funds holding DINO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aspiriant LLC's DINO Position: Q1 2017 in Review

Aspiriant LLC sold out of HF Sinclair (DINO) in Q1 2017, closing a stake of 18,605 shares — an estimated $610K sold.

Aspiriant LLC first reported a position in DINO in Q4 2016 and held it in 1 quarter. The position peaked at $610K in Q4 2016. 382 funds tracked by Wall St. Rank hold DINO as of Q1 2017.

Aspiriant LLC reported no remaining HF Sinclair position as of Q1 2017 after selling out during the quarter.
Aspiriant LLC sold 18,605 HF Sinclair shares in Q1 2017, an estimated $610K.
Aspiriant LLC first reported a position in HF Sinclair in Q4 2016 and held it in 1 quarter.
Aspiriant LLC's HF Sinclair position peaked at $610K in Q4 2016.
382 funds tracked by Wall St. Rank held HF Sinclair as of Q1 2017.

Based on Aspiriant LLC's 13F filing for Q1 2017, filed 15 May 2017.